Renol Polychem Stock Price Today (NSE: RNPL)

Renol Polychem

75.3512.45 (14.18%)
Market Open

Fundamental Score

...

Renol Polychem Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Renol Polychem share price today is 75.35, down 14.18% on NSE/BSE as of 17 June 2026. Renol Polychem (RNPL) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 115.98 (Cr). The 52-week high for RNPL share price is 156.00 and the 52-week low is 70.10. At a P/E ratio of 22.39x, RNPL is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 45.41% and a debt-to-equity ratio of 0.01.

Renol Polychem Share Price Chart — NSE/BSE Historical Performance

No data
High
141.00
Low
75.35
Volume
24.0K
Change
-36.38%

Renol Polychem share price chart: -36.38% return over the past month. 52-week high ₹156.00, 52-week low ₹70.10.

Renol Polychem — Last 10 Trading Days

DateOpenHighLowCloseVolume
75.3575.3575.3575.356.00K (Cr)
87.8087.8087.8087.807.20K (Cr)
134.00137.00132.00132.7026.40K (Cr)
136.05139.10134.00134.5073.20K (Cr)
136.00138.00135.00135.0032.40K (Cr)
141.00141.00135.00139.708.40K (Cr)
138.00139.00134.00138.7514.40K (Cr)
134.00138.00134.00138.006.00K (Cr)
137.00137.30135.00135.009.60K (Cr)
138.50138.50138.50138.501.20K (Cr)

Renol Polychem — Last 12 Months Price History

MonthOpenHighLowCloseChange
75.3575.3575.3575.35+0.00%
141.00141.0087.8087.80-37.73%
134.00139.00134.00138.75+3.54%
141.70141.70134.05135.00-4.73%
151.20151.95145.00145.00-4.10%
146.90151.95139.00150.00+2.11%
149.95156.00140.00141.00-5.97%
130.65146.20119.00145.05+11.02%
77.0082.9070.1075.00-2.60%
73.2576.9073.0076.90+4.98%

AI Research Briefing

Powered by Gemini · 2026-04-08

Overvalued micro-cap with high growth potential but significant liquidity and governance risks.

Research Confidence
6.0/10Moderate
MICRO-CAP DARK HORSEConsolidation - 1M: 35.19%, 3M: 90.85% (from brief).Expensive - P/E of 22.39x vs Industry P/E of 29.2x (from brief).

WHAT'S HAPPENING NOW (last 2-4 weeks)

Renol Polychem acquired an additional 11.02% stake in Harmony Ply-Lam Limited for million on March 27, 2026. Ankur Rastogi resigned as Company Secretary and Compliance Officer, effective March 31, 2026. Promoters declared no encumbrances on their shares for FY26.

CORE STORY (THE REAL GAME)

Why Now
  • Acquisition of Harmony Ply-Lam stake
  • Strong YoY sales growth
  • Positive outlook for India's specialty chemicals sector
Potential Catalysts
  • Significant order wins
  • Improved promoter holding
  • Expansion into new geographies
Key Risks
  • Micro-cap liquidity risk
  • Promoter stake decreasing
  • Dependence on raw material suppliers without long term agreements
Institutional Activity

Promoter stake decreased by -30.89% (from brief).

Macro Context

India's chemical production is projected to increase by 10.9% in 2026.

Order Book / Expansion

Renol Polychem acquired an additional 11.02% stake in Harmony Ply-Lam Limited for INR 90.0 million.

Cash Flow Quality

No - Free Cash Flow 5Y: ₹None Cr (from brief).

3–6 Month Outlook

Growth driven by domestic demand and global supply chain shifts. Monitor liquidity and promoter actions closely.

Primary Thesis Risk

Illiquidity and declining promoter stake can lead to a sharp correction.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

45.41%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

46.09%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Renol Polychem Valuation Check

Good

Price to Earnings (P/E)

22.39x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.20x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

69.10%

% shares held by company founders/management

Poor

FII Holding

0.68%

% shares held by foreign institutional investors

Poor

DII Holding

3.63%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

8.18%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

38.81%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.01x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

12.93x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Renol Polychem Fundamental Analysis & Valuation Benchmarking

Educational evaluation of RNPL across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Strong Return on Equity (45.41%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (46.09%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 22.39 vs Industry: 29.20)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Revenue Growth (38.81%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.01)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (12.93x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (69.10%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Limited Institutional Interest (FII+DII: 4.31%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Renol Polychem vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Renol Polychem with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
20.5/100
75
₹115.98
22.4
Average
45.41%
Excellent
46.09%
Excellent
0.0
Excellent
0.00%
60.4/100
1481
₹149466.57
66.6
Average
23.05%
Excellent
29.84%
Excellent
0.1
Excellent
12.63%
Good
12.49%
Good
0.68%
51.5/100
3682
₹37241.99
54.8
Average
8.29%
Poor
9.89%
Poor
0.2
Excellent
21.05%
Excellent
12.69%
Good
0.09%
40.6/100
7245
₹29462.02
66.3
Average
11.52%
Average
11.68%
Average
0.3
Excellent
-6.59%
Poor
17.22%
Excellent
0.21%
40.2/100
1715
₹21083.64
39.7
Average
13.36%
Average
16.28%
Good
0.2
Excellent
2.02%
Average
14.38%
Good
0.49%
52/100
3430
₹17807.40
46.3
Average
13.73%
Average
18.02%
Good
0.0
Excellent
57.98%
Excellent
14.83%
Good
0.49%
Atul Ltd...
ATUL500027
50.5/100
7003
₹17066.13
31.5
Average
9.10%
Poor
12.81%
Average
0.0
Excellent
-5.82%
Poor
6.41%
Good
0.43%
57.2/100
1325
₹16256.72
35.0
Average
15.75%
Good
20.61%
Excellent
0.0
Excellent
4.46%
Average
16.92%
Excellent
0.48%
37.5/100
1368
₹14036.52
92.8
Average
3.32%
Poor
7.33%
Poor
0.4
Excellent
11.97%
Good
22.13%
Excellent
0.06%
41.9/100
501
₹13796.68
51.3
Average
6.03%
Poor
6.32%
Poor
0.7
Good
-9.09%
Poor
11.68%
Good
0.26%
60.5/100
4677
₹13359.76
33.4
Average
19.47%
Good
26.39%
Excellent
0.0
Excellent
20.04%
Excellent
16.93%
Excellent
0.25%

Renol Polychem Quarterly Performance

Latest quarterly metrics for RNPL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

38.81%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

8.18%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Renol Polychem Technical Indicators

SMA 50, SMA 200, RSI and volume signals for RNPL — calculated from daily price history

11RSI 14
Oversold — RSI 11

Selling pressure is heavy — potential reversal zone.

SMA 50
143
▼ Price below SMA 50 — Short-term bearish
30-Day Avg Volume
26K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Renol Polychem Financial Statements

Annual income statement, balance sheet and cash flow for Renol Polychem (RNPL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Renol Polychem

About RNPL (Renol Polychem)

Renol Polychem (RNPL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current... market capitalisation of ₹115.98 (Cr). Renol Polychem has delivered a Return on Equity (ROE) of 45.41% and a ROCE of 46.09%. The debt-to-equity ratio stands at 0.01, reflecting the company's capital structure. Investors tracking RNPL share price can monitor key metrics including P/E ratio, promoter holding of 69.10%, and quarterly earnings growth.

Company Details

Symbol:RNPL
Industry:Specialty Chemicals
Sector:Specialty Chemicals
Website:N/A

RNPL Share Price: Frequently Asked Questions

What is the current share price of Renol Polychem?

Renol Polychem (RNPL) trades at ₹75.35 on NSE. Market cap ₹115.98 (Cr). Educational data only.

What is the P/E ratio of Renol Polychem?

Renol Polychem has a P/E of 22.39x vs industry average 29.20x.

What is the Bull Run score for Renol Polychem?

Renol Polychem has a Bull Run score of 20.5/100 based on 25+ financial parameters.

Does Renol Polychem pay dividends?

Renol Polychem has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Renol Polychem?

Renol Polychem has ROE of 45.41%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Renol Polychem?

Renol Polychem has debt-to-equity of 0.01.

Is Renol Polychem a good investment?

Bull Run gives Renol Polychem a score of 20.5/100. This is not investment advice — consult a SEBI-registered advisor.